C. Sabin
Statistics and Probability · 2000–2014
A researcher in the Science corpus: 12 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 6 citations into it
Whom C. Sabin trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Saad T. Bakir (in Statistics and Probability)
Papers from C. Sabin's perspective
Ordered by how strongly the researchers C. Sabin trusts endorse each paper. Same corpus, a different order for every researcher.
- Adverse effects of antiretroviral therapy. (The Lancet)
- Adjusting for multiple testing--when and how? (Journal of Clinical Epidemiology)
- Class-sparing regimens for initial treatment of HIV-1 infection. (New England Journal of Medicine)
- Prediction of coronary heart disease using risk factor categories.
- Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. (Journal of the American Medical Association (JAMA))
- Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. (New England Journal of Medicine)
- Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. (Archives of Internal Medicine)
- Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel
- Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 (Proceedings of the National Academy of Sciences of the United States of America)
- Marginal Structural Models
Their papers
- Targeting C-reactive protein for the treatment of cardiovascular disease (2006) — 711 citations
- Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. (2014) — 891 citations
- The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals (2010) — 462 citations
- Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. (2010) — 681 citations
- Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients (2008) — 921 citations
- Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients (2008) — 439 citations
- Class of antiretroviral drugs and the risk of myocardial infarction. (2007) — 1,446 citations
- Natural history and outcome in systemic AA amyloidosis. (2007) — 966 citations
- Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. (2006) — 1,231 citations
- Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study (2003) — 1,103 citations
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. (2002) — 1,651 citations
- Medical Statistics at a Glance (2000) — 877 citations